Atossa Therapeutics Begins Enrollment of Phase 2 Clinical Study of Oral Endoxifen in Sweden

NEXT STORY
The Global Molecular Biology Enzymes, Kits, and Reagents Market is expected to grow by $ 13.09 bn during 2021-2025, progressing at a CAGR of 14.61% during the forecast period
PREV STORY
iBio Announces Partial Adjournment of Annual Meeting of Shareholders to January 31, 2022
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Radius Health Presents Positive Data for TYMLOS™ (abaloparatide) Injection from the ACTIVExtend Trial at ASBMR 2017 Annual Meeting

ACTIVExtend trial demonstrated statistically significant fracture risk reduction through the 3.5 years of sequential ...

author_avatar
NASDAQ Market News

Forty Seven, Inc. to Present Updated Data from Ongoing Phase 1b/2 Clinical Trial of 5F9 in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma at 24th Congress of the European Hematology Association

author_avatar
NASDAQ Market News

Novartis erzielt im zweiten Quartal starke Umsätze, eine zweistellige Steigerung des operativen Kernergebnisses und lanciert Zolgensma und Piqray; Anhebung der Umsatz- und Gewinnerwartung

author_avatar
NASDAQ Market News